Literature DB >> 14632373

Stability as a distinction between Axis I and Axis II disorders.

M Tracie Shea1, Shirley Yen.   

Abstract

Temporal stability has served as a conceptual basis for the distinction between the clinical syndromes of Axis I disorders and the Axis II personality disorders, the latter being viewed as lifelong enduring patterns. However, comparisons of the stability of Axis I and II disorders have been limited. The present review examines findings from three naturalistic longitudinal studies that utilize similar methodology: the Collaborative Longitudinal Personality Disorders Study (CLPS; Gunderson et al., 2000), the Collaborative Depression Study (CDS; Katz & Klerman, 1979), and the Harvard/Brown Anxiety Research Program (HARP; Keller et al., 1994). Using a definition of remission/recovery as having no or minimal symptoms for 8 consecutive weeks, the courses of personality, depressive, and anxiety disorders were compared. Though remission/recovery rate at the 2-year follow-up was highest for mood disorders, the probability of recurrence was also particularly high. Personality disorders, with remission rates higher than the anxiety disorders, appear to be less stable than conceptualized. The anxiety disorders had remarkably low recovery rates even beyond 5 years of prospective follow-up. Factors that may explain these findings, as well as implications for future conceptualization of DSM, are discussed.

Entities:  

Mesh:

Year:  2003        PMID: 14632373     DOI: 10.1521/pedi.17.5.373.22973

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  16 in total

1.  EXPLORING PERSONALITY DIAGNOSIS STABILITY FOLLOWING ACUTE PSYCHOTHERAPY FOR CHRONIC POSTTRAUMATIC STRESS DISORDER.

Authors:  John C Markowitz; Eva Petkova; Tatyana Biyanova; Ke Ding; Eun Jung Suh; Yuval Neria
Journal:  Depress Anxiety       Date:  2015-10-06       Impact factor: 6.505

2.  Predictors of remission from body dysmorphic disorder: a prospective study.

Authors:  Katharine A Phillips; Maria E Pagano; William Menard; Christina Fay; Robert L Stout
Journal:  J Nerv Ment Dis       Date:  2005-08       Impact factor: 2.254

3.  A 12-month follow-up study of the course of body dysmorphic disorder.

Authors:  Katharine A Phillips; Maria E Pagano; William Menard; Robert L Stout
Journal:  Am J Psychiatry       Date:  2006-05       Impact factor: 18.112

4.  Stable "trait" variance of temperament as a predictor of the temporal course of depression and social phobia.

Authors:  Kristin Naragon-Gainey; Matthew W Gallagher; Timothy A Brown
Journal:  J Abnorm Psychol       Date:  2013-08

Review 5.  Continuity of axes I and II: toward a unified model of personality, personality disorders, and clinical disorders.

Authors:  Robert F Krueger
Journal:  J Pers Disord       Date:  2005-06

6.  The joint structure of DSM-IV Axis I and Axis II disorders.

Authors:  Espen Røysamb; Kenneth S Kendler; Kristian Tambs; Ragnhild E Orstavik; Michael C Neale; Steven H Aggen; Svenn Torgersen; Ted Reichborn-Kjennerud
Journal:  J Abnorm Psychol       Date:  2011-02

7.  What is the effect on comorbid personality disorder of brief panic-focused psychotherapy in patients with panic disorder?

Authors:  John R Keefe; Barbara L Milrod; Robert Gallop; Jacques P Barber; Dianne L Chambless
Journal:  Depress Anxiety       Date:  2017-12-06       Impact factor: 6.505

8.  Controversies surrounding classification of personality disorder.

Authors:  Youl-Ri Kim; Peter Tyrer
Journal:  Psychiatry Investig       Date:  2010-02-08       Impact factor: 2.505

Review 9.  Neuroticism and common mental disorders: meaning and utility of a complex relationship.

Authors:  Bertus F Jeronimus; Roman Kotov; Johan Ormel; Harriëtte Riese; Elisabeth H Bos; Benjamin Hankin; Judith G M Rosmalen; Albertine J Oldehinkel
Journal:  Clin Psychol Rev       Date:  2013-04-29

10.  The stability of DSM personality disorders over twelve to eighteen years.

Authors:  Gerald Nestadt; Chongzhi Di; J F Samuels; O J Bienvenu; I M Reti; P Costa; William W Eaton; Karen Bandeen-Roche
Journal:  J Psychiatr Res       Date:  2009-08-04       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.